Stay updated on Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.

Latest updates to the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe Taiwan site entry was updated from 'Taoyuan, Taiwan, 33305' to 'Taoyuan City, Taiwan, 33305' to reflect the correct administrative designation for the Taoyuan location in the study's locations.SummaryDifference0.0%

- Check17 days agoChange DetectedA site interface revision was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check24 days agoChange DetectedThe page now displays Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

- Check53 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page revision entry was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check89 days agoChange DetectedThe page revision updated from v3.4.1 to v3.4.2, a minor technical update that does not affect study details or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zimberelimab Combo vs Pembrolizumab with Chemo in NSCLC Clinical Trial page.